StonvexLoading…
StonvexStonvexStonvexCore line items from EDIT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.83M | $40.52M | $15.78M | $8.24M |
Operating Income | $-25.00M | $-160.01M | $-152.25M | $-127.71M |
Net Income | $-24.98M | $-160.06M | $-154.44M | $-53.23M |
EPS (Diluted) | $-0.26 | $-1.80 | $-1.80 | $-1.54 |
Total Assets | $149.34M | $186.53M | $201.75M | $210.58M |
Total Liabilities | $144.93M | $159.25M | $188.30M | $191.39M |
Cash & Equivalents | $123.65M | $146.65M | $165.65M | $138.54M |
Free Cash Flow OCF − CapEx | $-23.15M | $-165.85M | $-129.40M | $-98.13M |
Shares Outstanding | 97.87M | 97.87M | 93.26M | 87.39M |